Pathoquest retweeted
PathoQuest obtains Pharmaceutical Establishment status from French ANSM to meet big pharmas’ expectations for the quality control of biologics pathoquest.com/?p=57843 @Pathoquest More French life science business news at [LSF] at life-sciences-france.com/new…
Pathoquest retweeted
We are thrilled to announce the addition of high-throughput technologies and expanded pharmacokinetic services to our portfolio. Learn more about our expanded services for Early Discovery Screening: bit.ly/2reVIZ4
Pathoquest retweeted
Charles River Laboratories And PathoQuest Expand Strategic Biologics Partnership #CharlesRiver #pharma #PathoQuest #biologics hubs.ly/H0bCV7P0
Pathoquest retweeted
We are excited to announce the expansion of our strategic partnership with @Pathoquest. This agreement allows us to provide next-generation sequencing (NGS) services to the biologics industry. Learn more: lnkd.in/e5kr9xe
Pathoquest retweeted
Interested in learning more about the power of High Throughput Sequencing (HTS)? @PathoQuest's upcoming webinar will provide real life examples of HTS and bioinformatics analysis. Learn more: bit.ly/2l5z1Hv
Pathoquest retweeted
Learn how the power of metagenomics is changing for biosafety testing. Join our webinar with @PathoQuest on 5/17. bit.ly/2p4pe5y
Pathoquest retweeted
Dr. Hélène Peyro-Saint-Paul, CMO @Pathoquest will present on metagenomics & pathogen detection @illumina booth today at 1:00 #ECCMID2017 – at Vienna, Austria
Pathoquest retweeted
Sécuriser les bioproductions : les nouvelles solutions de métagénomique @Pathoquest bit.ly/2imtxUX Présent à Bioproduction vol6 !
Pathoquest retweeted
Learn how we’re working with @Pathoquest to offer their NGS-based testing solution to our customers: bit.ly/2hMco3J
Pathoquest retweeted
We are pleased to begin a partnership with @PathoQuest to offer their NGS-based testing solution to our customers. bit.ly/2dy50dT















